Innovators

Innovators seeking funding

Innovators in UK Life Sciences are developing world-class science with the potential to transform patient lives, fuel sector growth, and deliver outstanding returns.

But even our most innovative ideas are struggling to access the right investment at the right time. Fragmented pathways, unclear market signals, and high investor caution result in too many promising ideas stalling before they can scale.

We are here to help change that, thanks to a promise made by Medicines Discovery Catapult (MDC)  to channel its earnings for reinvestment to build a stronger UK Life Sciences sector.

As a new, early-stage impact investor, we are ready to back breakthroughs. We connect high-potential ventures with the investors, capital or counsel they need to move more quickly and more successfully towards translation.

We serve as a bridge to MDC’s scientific, translational and industrial expertise, and beyond to the Life Sciences investment ecosystem.

First, we utilise our national view and our exceptional due diligence to identify the science that meets real demand. Our market insight and unique access to MDC’s world-class scientists, technologies and networks mean we can then test the potential of an idea and enable its route to investment.

Only when the best ideas are made ‘fit-to-fund’ do we put them forward to our investor partners.

With MDV behind you, your science stands out for all the right reasons — evidence, credibility, and impact.

By partnering with us, your breakthrough has the best chance to succeed.